Natural angiotensin converting enzyme inhibitors: A safeguard against hypertension, respiratory distress syndrome, and chronic kidney diseases
Phytotherapy Research · 2023-12 · 37 (12) · 5464-5472
DOI: 10.1002/ptr.7987 ↗At a glance
Übersichtsarbeit in Phytotherapy Research, published online on 2023-09-07. Written by Aya Khaled and 10 co-authors. Institution: Pharmacognosy Department, Faculty of Pharmacy, Heliopolis University, Cairo, Egypt. Major MEDLINE topics: Hypertension, Renal Insufficiency, Chronic, Respiratory Distress Syndrome. Cited 21 times so far (Crossref); 45 references.
Abstract (original language)
Hypertension is a serious concern as it is one of the causes of kideny failure and pulmonary fibrosis. An important therapeutic strategy for treating chronic hypertension is to inhibit the angiotensin converting enzyme (ACE). ACE inhibition reduces kidney damage, pulmonary artery pressure, and high blood pressure. Due to their high efficacy and low risk of side effects, natural renin‐angiotensin system inhibitors have drawn increasing attention over the past decades. Alkaloids, amino acids, anthocyanidins, flavonoids, glucosinolates, isoflavonoids, phenolic acids, polyphenolics, and triterpenoids are among the bioactive metabolites pocessing an impressive ACE inhibitory activity. Many herbs including Rosmarinus officinalis , Hibiscus sabdariffa , Curcuma longa , Rauwolfia serpentina , Emblica officinalis , Cynara scolymus , Punica granatum , Mucuna pruriens , Capsicum annuum , and Moringa olifera were found having ACE inhibitory activities comparable to captopril and enalpril. These enticing natural ACE inhibitors deserve to be a safeguard medicine against hypertension, respiratory distress syndrome, and chronic kidney diseases. More clinical trials are required before new natural compounds and herbs can be used to treat chronic hypertension and its ramifications, such as respiratory distress syndrome and kidney failure.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Pharmacognosy Department, Faculty of Pharmacy, Heliopolis University, Cairo, Egypt.
- School of Pharmacy, University of Camerino, Camerino, Italy.
- Pharmacognosy Department, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
- Department of Pharmaceutical Sciences, College of Pharmacy, Gulf Medical University, Ajman, United Arab Emirates.
ORCID profiles: Omar M Sabry
Cite
APA
Khaled, A., Ahmed, E., Mamdouh, M., Saad, H., Mohamed, A., Sobhy, M., Piatti, D., Sabry, M., Saad, M. A., Sabry, O. M., & Caprioli, G. (2023). Natural angiotensin converting enzyme inhibitors: A safeguard against hypertension, respiratory distress syndrome, and chronic kidney diseases. Phytotherapy Research, 37(12), 5464-5472. https://doi.org/10.1002/ptr.7987
Vancouver
Khaled A, Ahmed E, Mamdouh M, Saad H, Mohamed A, Sobhy M, et al. Natural angiotensin converting enzyme inhibitors: A safeguard against hypertension, respiratory distress syndrome, and chronic kidney diseases. Phytotherapy Research. 2023;37(12):5464-5472. doi:10.1002/ptr.7987
BibTeX
@article{Khaled2023,
author = {Khaled, Aya and Ahmed, Esraa and Mamdouh, Mohamed and Saad, Hager and Mohamed, Aya and Sobhy, Marina and Piatti, Diletta and Sabry, Miral and Saad, Muhammed A and Sabry, Omar M and Caprioli, Giovanni},
title = {Natural angiotensin converting enzyme inhibitors: A safeguard against hypertension, respiratory distress syndrome, and chronic kidney diseases},
journal = {Phytotherapy Research},
year = {2023},
volume = {37},
number = {12},
pages = {5464--5472},
doi = {10.1002/ptr.7987}
}
EUVIMED